14.84
price up icon2.27%   0.33
after-market Dopo l'orario di chiusura: 14.84
loading

Janux Therapeutics Inc Azioni (JANX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
100.00%
-
10.00 - - -
Operating Expenses
6.30%
42.40
45.25 - - 29.02
Benefits Costs and Expenses
6.90%
31.95
34.31 - - 20.22
Costs And Expenses
6.90%
31.95
34.31 - - 20.22
Operating Income/Loss
20.28%
-42.40
-35.25 -45.12 -34.90 -29.02
Nonoperating Income/Loss
4.42%
10.46
10.94 11.26 11.39 8.806
Income/Loss From Continuing Operations Before Tax
31.39%
-31.95
-24.31 -33.86 -23.51 -20.22
Income/Loss From Continuing Operations After Tax
31.39%
-31.95
-24.31 -33.86 -23.51 -20.22
Net Income/Loss
31.39%
-31.95
-24.31 -33.86 -23.51 -20.22
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.90%
0.0602
62.02 61.90 61.79 1.0345
Diluted Average Shares
99.90%
0.0602
62.02 61.90 61.79 1.0345
Basic Earnings Per Share
30.77%
-0.51
-0.39 -0.55 -0.38 -0.35
Diluted Earnings Per Share
30.77%
-0.51
-0.39 -0.55 -0.38 -0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$99.12
price up icon 0.49%
$28.33
price up icon 1.76%
$48.57
price up icon 0.16%
$91.18
price up icon 1.97%
ONC ONC
$310.79
price up icon 0.76%
$162.43
price down icon 1.47%
Capitalizzazione:     |  Volume (24 ore):